Newsfeeds - Spark Newswire

1 minute read

Entrada Therapeutics Q4 EPS $(0.79) Beats $(0.83) Estimate

March 6, 8:20 AM

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.83) by 4.82 percent. This is a 11.24 percent increase over losses of $(0.89) per share

TRDA

4 minute read

Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

February 15, 3:04 PM

Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.

ABNB

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

February 15, 1:31 PM

Gainers TransCode Therapeutics (NASDAQ:RNAZ) stock rose 55.5% to $0.73 during Wednesday’s regular session. As of 12:30 EST, TransCode…

GLYC

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

December 20, 1:31 PM

Gainers Athenex (NASDAQ:ATNX) stock moved upwards by 41.4% to $0.19 during Tuesday’s regular session. Trading volume for this…

ATNX

3 minute read

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

By Lisa Levin

December 20, 7:13 AM

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.

ADXN

1 minute read

Nike, General Mills And 3 Stocks To Watch Heading Into Tuesday

By Lisa Levin

December 20, 5:08 AM

With US stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

FDS

1 minute read

Why Entrada Therapeutics Stock Is Diving After Hours

By Adam Eckert

December 19, 5:49 PM

Entrada Therapeutics Inc (NASDAQ: TRDA) shares are trading lower in Monday's after-hours session after the company said it received a clinical hold notice from the

TRDA

1 minute read

Entrada Therapeutics Announces Clinical Hold On IND Application For ENTR-601-44 In Duchenne Muscular Dystrophy

By Benzinga Newsdesk

December 19, 5:37 PM

Entrada Therapeutics, Inc. (NASDAQ:TRDA), a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™)-therapeutics as a new class of

TRDA

5 minute read

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

December 13, 1:14 PM

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

ACMR